expansion
Eli Lilly Invests $3 Billion in Wisconsin Manufacturing Expansion to Meet Growing Demand for Diabetes and Obesity Medicines
Eli Lilly, Wisconsin, manufacturing expansion, diabetes, obesity, pharmaceuticals, investment, job creation
Amgen Expands in North Carolina with $1 Billion Biomanufacturing Facility
Amgen, North Carolina, biomanufacturing, facility expansion, pharmaceutical industry
Philips and AWS Strengthen Strategic AI Partnership, Expanding Cloud-Enabled Diagnostics to Europe
Philips, AWS, Strategic AI Collaboration, Cloud-Enabled Diagnostics, European Expansion, Healthcare Innovation, Integrated Diagnostics Portfolio, Generative AI Applications
Incyte Unveils Promising Monjuvi Data at ASH24, Paving Way for FDA Label Expansion in Follicular Lymphoma
Incyte, Monjuvi, ASH24, Follicular Lymphoma, Label Expansion, FDA, Phase 3 Trial
GSK Invests $800 Million in Pennsylvania Site Expansion to Boost Vaccine and Medicine Production
GSK, Pennsylvania, manufacturing expansion, vaccine production, medicine manufacturing, $800 million investment
Nucleus RadioPharma Unveils Ambitious Expansion Plan to Triple Production Capacity and Create 100 New Positions
Nucleus RadioPharma, Radiopharma CDMO, Manufacturing Expansion, Job Creation, Radiopharmaceuticals, Radiotherapeutics
Catalent Sells New Jersey Facility and HQ to Ardena, Expanding Belgian CDMO’s US Footprint
Catalent, Ardena, New Jersey manufacturing plant, HQ sale, CDMO expansion, pharmaceutical manufacturing
Bayer Seeks to Broaden Nubeqa’s Use in Prostate Cancer with Chemotherapy-Free Treatment Option
Nubeqa, Bayer, prostate cancer, chemotherapy-free, label expansion, ARANOTE trial, darolutamide, androgen deprivation therapy (ADT), metastatic hormone-sensitive prostate cancer (mHSPC)
Eli Lilly Expands Irish Manufacturing with Additional $1B Investment
Eli Lilly, Ireland, manufacturing expansion, biologics, pharmaceuticals, investment, Limerick, Kinsale
Novartis Expands Radioligand Therapy Production with Two New US Facilities
Novartis, radioligand therapy, RLT, cancer treatment, manufacturing facilities, US expansion